XBiotech Inc XBIT
Key Stats
- Today's Range
- $2.42 – $2.44
- 50-Day Range
- $2.17 – $2.65
- 52-Week Range
- $2.09 – $3.61
- Volume
- 10K shs
- Average Volume
- 25K shs
- Market Cap
- $74.39 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 0.55
- Price / Sales
- —
Short Interest
- Short Interest
- 17.67%
- Days to Cover
- 70.49
About XBiotech Inc
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.